International Business Machines Corp (IBM) 161.94 $IBM 3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
International Business Machines Corp (IBM) 161.94 $IBM

3 Reasons International Business Machines Corp. Stock Could Fall
Leo Sun, The Motley Fool - Motley Fool - Sat Feb 28, 11:17AM CST
Shares of IBM have fallen 13% over the past 12 months, woefully underperforming a 14% gain for the  S&P 500 . Revenue  has declined for 11 consecutive quarters as it struggles to dump lower-margin businesses and...
IBM: 161.94 (+1.07), IT: 83.11 (-0.49), MSFT: 43.85 (-0.21), ACN: 90.03 (-0.27), AAPL: 128.46 (-1.95)

Top 10 Warren Buffett Stock Buys for 2015: IBM, Visa, Deere and More
at The Street - Sat Feb 28, 9:48AM CST
Here's a closer look at 10 stocks that Berkshire Hathaway bought in the most recently reported quarter.
SU: 30.10 (-0.38), QSR: 44.23 (+0.75), V: 271.31 (-2.44), IBM: 161.94 (+1.07), CHTR: 180.60 (-1.58), FOXA: 35.00 (+0.19), DE: 90.60 (-0.58), VIAB: 69.94 (+0.33), PCP: 216.30 (-0.80), MA: 90.13 (-1.13)

IBM Is Finally Ready To Create Real Shareholder Value
Brian Nichols - at Seeking Alpha - Sat Feb 28, 2:54AM CST

IBM: 161.94 (+1.07)

IBM: Big Iron Will Help Big Blue To A Big 2015
Anchorite - at Seeking Alpha - Fri Feb 27, 4:22PM CST

IBM: 161.94 (+1.07)

Dow Jones (DJIA) Today: International Business Machines (IBM) Leads The Day Higher, Visa (V) Lags
at The Street - Fri Feb 27, 3:30PM CST
The Dow component that led the way higher today was International Business Machines (NYSE:IBM), which sported a $1.07 gain (+0.7%) bringing the stock to $161.94. Holding the Dow back today was Visa (NYSE:V), which lagged the broader Dow index with a...
V: 271.31 (-2.44), IBM: 161.94 (+1.07)

Splunk Remains a Risky Bet Despite Its Fast Revenue Growth
at The Street - Fri Feb 27, 2:44PM CST
The software company is still losing money on a GAAP basis.
IBM: 161.94 (+1.07), WDAY: 85.50 (-3.15), SPLK: 67.25 (-2.32), ORCL: 43.82 (-0.07), CRM: 69.38 (-0.86)

Infoblox Has 'Mojo Back' After Q2 Earnings Beat
at Investor's Business Daily - Fri Feb 27, 12:47PM CST
Infoblox (BLOX) appears to have gotten its mojo back after the network management services company reported fiscal Q2 earnings after the close Thursday that soundly beat analyst estimates. So concludes Amitabh Passi, an analyst for UBS Securities, in...
IBM: 161.94 (+1.07), BLOX: 23.25 (+2.02)

Jim Cramer on the Stock Market: Exodus From Old Tech Continues
at The Street - Fri Feb 27, 8:28AM CST
As the transition plays out, who's got game?
MNST: 141.12 (+16.38), IBM: 161.94 (+1.07), SPLK: 67.25 (-2.32), TWTR: 48.08 (-1.33), DATA: 94.01 (-3.41), HPQ: 34.84 (+0.83), GOOG: 558.40 (+2.92)

Ingram Micro Q4 Earnings In Line; Shares Dip on Soft Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 8:12AM CST
Ingram Micro Inc. (IM) reported fourth-quarter 2014 non-GAAP earnings of 98 cents per share, in line with the Zacks Consensus Estimate.
IM: 24.71 (-2.52), IBM: 161.94 (+1.07), CRUS: 30.11 (-0.12), JNPR: 23.91 (-0.20)

The Best All-Around Stock in the Market
Matthew Frankel, The Motley Fool - Motley Fool - Fri Feb 27, 8:05AM CST
What are the best stocks to buy right now? Maybe you should buy financials like Wells Fargo as a play on the continued economic recovery, or oil companies like ExxonMobil while prices remain depressed. Or maybe your money should be used to buy...
KO: 43.30 (+0.84), PSX: 78.46 (-1.60), GE: 25.99 (+0.10), AXP: 81.59 (-1.66), XOM: 88.54 (-0.11), WMT: 83.93 (+0.13), COP: 65.20 (-0.65), WFC: 54.79 (-0.36), UPS: 101.73 (-0.13), NOV: 54.35 (+1.08), JNJ: 102.51 (-0.29), V: 271.31 (-2.44), GS: 189.79 (-2.41), USB: 44.61 (-0.32), IBM: 161.94 (+1.07), COST: 146.96 (+0.31), GM: 37.31 (-0.25), PG: 85.13 (-0.04), VZ: 49.45 (+0.08), MA: 90.13 (-1.13)

Investing In IBM Stock – Is Warren Buffett Right To Hold The Big Blue?
Ben Reynolds - Amigobulls - Thu Feb 26, 11:00PM CST
Investing In IBM- IBM stock analysis revelas that IBM stock is undervalued based on the latest Q4 results and the expected operating earnings decline.
IBM: 161.94 (+1.07)

IBM targets $4 bil to key items
at Investor's Business Daily - Thu Feb 26, 5:32PM CST
The computer, software and consulting giant said at its annual meeting with analysts that it will shift $4 bil of '15 spending to high growth markets including cloud computing, data analytics, mobile, social and security, various reports said. CEO...
IBM: 161.94 (+1.07), HPQ: 34.84 (+0.83)

The Aging Of The Tech Sector: The Pricing Divergence Of Young And Old Tech Companies
Aswath Damodaran - Seeking Alpha - Thu Feb 26, 4:13PM CST
As the Nasdaq approaches historic highs, Apple's (NASDAQ: AAPL ) market cap exceeds that of the Bovespa (the Brazilian equity index) and young social media companies like Snapchat have nosebleed valuations, there's talk of a tech bubble again. It is...
LNKD: 267.20 (-3.56), IBM: 161.94 (+1.07), FB: 78.97 (-1.44), TWTR: 48.08 (-1.33), AAPL: 128.46 (-1.95)

Crude Oil Selloff Fails to Scare Stocks From Record Highs
at The Street - Thu Feb 26, 3:20PM CST
The S&P 500 and Dow Jones Industrial Average slip from record highs on Thursday, but not by much in another day characterized by trading in a narrow bracket.
KSS: 73.80 (+2.11), CHTR: 180.60 (-1.58), XOM: 88.54 (-0.11), SHLD: 37.60 (+1.55), MS: 35.79 (-0.27), T: 34.56 (+0.06), RDS.A: 65.37 (+0.55), IBM: 161.94 (+1.07), SCTY: 51.36 (-0.74), BP: 41.44 (+0.08), GOOGL: 562.63 (+3.34), TWC: 154.05 (+1.65), CVX: 106.68 (-0.38), VZ: 49.45 (+0.08), CMCSA: 59.38 (+0.23), AVGO: 127.62 (-1.63), XLE: 79.02 (-0.35), CRM: 69.38 (-0.86)

S&P 500, Dow Slip From Records as Energy Selloff Trumps Tech Rally
at The Street - Thu Feb 26, 2:29PM CST
The S&P 500 and Dow move off record highs.
KSS: 73.80 (+2.11), CHTR: 180.60 (-1.58), SHLD: 37.60 (+1.55), MS: 35.79 (-0.27), T: 34.56 (+0.06), IBM: 161.94 (+1.07), SCTY: 51.36 (-0.74), GOOGL: 562.63 (+3.34), TWC: 154.05 (+1.65), VZ: 49.45 (+0.08), CMCSA: 59.38 (+0.23), AVGO: 127.62 (-1.63), CRM: 69.38 (-0.86)

IBM Is Aiming for $40 Billion of Revenue From Five Growth Areas
at The Street - Thu Feb 26, 1:46PM CST
IBM will tell investors Thursday that it will continue to remain a 'high-value innovation company,' even if Wall Street doesn't currently think so.
SPY: 210.66 (-0.72), IBM: 161.94 (+1.07), AAPL: 128.46 (-1.95)

Is Nasdaq's Move to 5,000 Different This Time or Are Stocks Undervalued?
at The Street - Thu Feb 26, 1:30PM CST
As the Nasdaq approaches the 5,000 mark, the CNBC 'Fast Money Halftime' trading panel examines whether this time is different.
VXX: 27.62 (-0.16), IBM: 161.94 (+1.07), GILD: 103.53 (-0.66), QCOM: 72.51 (+0.50), MSFT: 43.85 (-0.21), INTC: 33.25 (-0.40), AAPL: 128.46 (-1.95)

Dow Jones (DJIA) Today: International Business Machines (IBM) Lower
at The Street - Thu Feb 26, 1:00PM CST
Holding back the Dow today is International Business Machines (NYSE:IBM), which is lagging the broader Dow index with a $1.74 decline (-1.1%) bringing the stock to $161.07.
IBM: 161.94 (+1.07)

Notes On The 2015 IBM Investor Briefing
Early Retiree - at Seeking Alpha - Thu Feb 26, 11:21AM CST

IBM: 161.94 (+1.07)

Cramer: 'Takeover Thursday' Shows M&A Activity Remains Healthy
at The Street - Thu Feb 26, 10:31AM CST
Jim Cramer takes a look at a number of deals in what he's calling 'Takeover Thursday,' including Avago Technologies buying Emulex and Iberdrola buying UIL Holdings.
ELX: 7.95 (+0.02), IBM: 161.94 (+1.07), AAPL: 128.46 (-1.95), UIL: 50.55 (-1.52), AVGO: 127.62 (-1.63), CYBX: 68.50 (+1.90)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

Updated Category News Views 2

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 1

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
AI Platform Suno Sued for Exploiting Artists' Identities

Updated Category News Views 1

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Continue Reading
Rackspace Lawsuit Deadline: Investors Must Take Action

Updated Category News Views 2

Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 0

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Art and Science Blend in Dr. De La Cruz's Approach

Updated Category News Views 2

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 1

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Faruqi & Faruqi Urge Wix Investors to Act Now

Updated Category News Views 3

Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...

Continue Reading

Top 5 Most Recently Viewed Articles

Executive Shifts at Title Resources Group: Key Leadership Updates

Updated Category News Views 233

Leadership Changes at Title Resources Group Title Resources Group (TRG), a leading title insurance underwriter, is undergoing an important executive transition. Kevin Wall is set to be appointed as the new Chief Executive Officer (CEO), succeeding J. Scott McCall, who will transition to the role of Vice Chairman of the Board of Directors. This strategic move, reflecting...

Continue Reading
Bear Stewart Recall: Soy Allergy Alert Shakes Confidence

Updated Category News Views 56

Undeclared Ingredients: Not Just Another Casual Glitch Well, here we go again. Bear Stewart LLC's latest revelation sends alarm bells ringing for anyone with a nose for allergic disorders. Their Bakr Brown Butter Chocolate Chunk Ready To Bake Cookie Dough found its way to store shelves with an ingredient that can cause mayhem for many – soy. Imagine thinking you’re...

Continue Reading
Exploring the Impact of Inclusivity in Global Advertising

Updated Category News Views 134

The Importance of Inclusive Advertising In today's dynamic advertising landscape, inclusivity plays a critical role in how brands connect with their audiences. Inclusivity isn't just a buzzword; it's becoming essential for brands aiming to resonate with diverse demographics, reflecting the world we live in. XR Extreme Reach, a leading global technology company, has taken...

Continue Reading
Suburban Propane Partners with Local Organizations for Community Support

Updated Category News Views 117

Suburban Propane's Commitment to Community Well-being Suburban Propane Partners, L.P. (NYSE: SPH), a leading provider of propane and renewable energy solutions, is dedicated to making a positive impact in local communities. Recently, they partnered with Sharing House, a community organization focused on assisting those in need. This collaboration aimed to gather essential...

Continue Reading
GoHealth Inc. Achieves New Heights with Stock Performance

Updated Category News Views 227

GoHealth's Significant Stock Surge Recently, GoHealth Inc. (GOCO) has made headlines as it reached a remarkable milestone by hitting a 52-week high of $14.94. This achievement illustrates a substantial 12% gain over the past week and a phenomenal 40% surge over the last six months. Investors and market analysts have been captivated by these developments, considering the...

Continue Reading